This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Biktarvy
  • /
  • Safety and Efficacy of Switching From Dolutegravir...
Clinical trial

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Read time: 3 mins
Last updated:11th Nov 2015
Identifier: NCT02603120
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest